Neurology · 2005 · 120 citations · 3 references
MedicineNeurologyPharmacologyImmunopharmacotherapyNeuroimmunologyPsychoneuroimmunologyMultiple SclerosisMultiple Sclerosis PharmacotherapyClinical Adverse Effects
Pharmacotherapeutic options for multiple sclerosis (MS)-related fatigue are limited. Thirty patients were randomly assigned to aspirin (ASA) 1,300 mg/day or placebo in a double-blind crossover study. Results favored ASA for the main clinical outcomes: Modified Fatigue Impact Scale scores (p = 0.043) and treatment preference (p = 0.012). There were no significant adverse effects. The results warrant further study and support a role for ASA-influenced mechanisms, perhaps immunologic, in the generation of MS-related chronic fatigue.
3
Fatigue and declines in cognitive functioning in multiple sclerosis
Lauren Krupp, Leigh E. Elkins · Neurology · 2000 · 284 citations
Medicine, Neurology, Psychology +17
Quantitative assessment of motor fatigue and strength in MS
S. R. Schwid, Charles A. Thornton, S. Pandya et al. · Neurology · 1999 · 239 citations